塔克罗利斯的刺激反应性聚合物合物:一种pH/Redox触发的方法,用于精确的药物输送
Yashika Sharma1,2, Davinder Singh1,3, Saika Saman4
1Natural Products and Medicinal Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
ACS applied bio materials
|December 5, 2025
概括
研究人员开发了含有塔克罗利斯 (TAC) 的双pH和氧化还原反应敏捷的氨酸 (HA) 菌粒. 这些新型纳米结构显示出有针对性药物递送的潜力,通过CD44受体介导的内细胞分裂显示出良好的生物相容性和高效的细胞吸收.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物运输 药物运输 药物运输
背景情况:
- 塔克罗利 (TAC) 是一种免疫抑制剂,口服生物利用性有限.
- 开发有针对性的药物输送系统可以提高TAC的有效性并减少副作用.
- 响应性纳米载体提供了在特定地点控制药物释放的潜力.
研究的目的:
- 为了合成和表征双重pH和氧化还原反应的塔克罗利斯的宏分子前药物.
- 为了评估由药物加载和释放性质的结合物形成的细胞纳米结构.
- 研究开发的纳米细胞的细胞吸收机制和生物相容性.
主要方法:
- 氨酸 (HA) 与囊胺的逐步结合,化功能化,并与酸盐修饰的塔克罗利斯 (TAC) 合.
- 使用1H NMR对合物 (HSNT) 的表征.
- 使用传输电子显微镜 (TEM) 和动态光散射 (DLS) 分析状纳米结构.
- 药物装载能力的确定.
- 使用HCT-116细胞和CD44受体阻断的细胞吸收研究.
- 血液溶解试验,以评估生物相容性.
主要成果:
- 成功合成了HA-cystamine-hydrazide-tacrolimus (HSNT) 结合物,形成了稳定的小粒纳米结构 (~200 nm).
- 在TAC方面实现了10.24%的高药物装载能力.
- 在HCT-116细胞中证实了HSNT菌根的CD44受体介导的内细胞分裂.
- 证明了纳米细胞的非溶血性质和良好的生物相容性.
结论:
- 开发出的双响应的聚合物微粒 (HSNT) 是一个有前途的纳米载体的tacrolimus.
- 该系统表现出高效的细胞吸收和有利的生物相容性.
- 为了潜在的临床应用,需要进一步进行翻译性研究.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Modified-Release Drug Delivery Systems: Classification
318
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
318
Modified-Release Drug Delivery Systems: Rate-Programmed I
174
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
174
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
165
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
165


